Mosaic Biosciences’ Post

JAX Study Director Aaron Rose explores how biological therapeutics are reshaping the traditional drug development process and why #humanizedmodels are essential for advancing biologics programs in this new JAX On-Demand video!

Oligonucleotide therapeutics are new drugs that can target specific genes and diseases. But how can we check their quality and safety? In this article, we show you a new workflow for impurity analysis of oligonucleotides using the LCMS-9050 and LabSolutions Insight Biologics. This workflow is fast, sensitive, and accurate for finding and identifying impurities in these drugs. Read more here: https://zurl.co/Xlfg Share your thoughts and questions with us below! #Shimadzu #LCMS #ImpurityAnalysis

Our very own Associate Director of CMC, Ashley Taylor, highlighted this article by LifeTein.com on the benefits of stapled peptides. Stapled peptides are breaking new ground in drug development, offering enhanced stability and efficacy for targeting previously undruggable interactions. What are your thoughts on the future of peptide therapeutics? Check out the article and let us know! https://lnkd.in/embS6_di #BiotechInnovation #PeptideTherapeutics #DrugDevelopment

As a science-led biotechnology firm developing prescription digital therapeutics, Click Therapeutics recognizes the important role that FDA plays to ensure that patients receive safe and effective treatments. Recently, FDA published a perspective on navigating the regulatory landscape and specifically referenced digital therapeutics, sharing that “Digital therapeutics is another area of novel therapy development that holds the potential for increased, and potentially rapid, access for patients.” We are thrilled to see the team at FDA supportive of the potential of digital therapeutics to increase access to high-quality therapies for patients. To read more on this perspective, visit: https://lnkd.in/eq9eTUwv #DigitalTherapeutics

Thoughts on this? >> Merck pens pact with Pearl Bio for new biologics in cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharma #healthcare #pharmaceutical

Thoughts on this? >> Merck pens pact with Pearl Bio for new biologics in cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #productmarketing #biotech #healthcare

Thoughts on this? >> AI-powered biologics biotech Abiologics launches with $50M backing from Flagship >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #pharmaceutical #healthcare

BIO-PHARMA: Traditionally, the pharmaceutical landscape has been dominated by small molecules. In contrast to this dominance, #biologics have become the leading molecule type within the solid tumor indication, accounting for 64% of drugs. https://lnkd.in/dpHTh5ti GlobalData Plc GlobalData Healthcare #biosimilars #vaccines #biopharma #biotech #marketresearch #data #biovoicenews

Multiparameter flow cytometry has been used for cell analysis for decades, and now that cells themselves are being used as therapeutics, this technology is able to provide critical information around the safety and efficacy of cell-based therapeutics. Watch our webinar to learn how this technology provides critical information in support of drug development.https://bit.ly/44xyAGp #clinicalresearch #bioanalysis #flowcytometry

Recently, oligonucleotides have been widely developed in the biopharmaceutical industry for use as human drugs, both as therapeutics and as vaccines. Oligonucleotides encompass a wide range of sizes and products including small interfering RNAs (siRNA) and microRNA (miRNA) products, plasmid DNA (pDNA), and messenger RNA (mRNA) vaccines. Learn more about the challenge of analytical testing oligonucleotide products and the different levels of support required from William Boomershine, Ph.D. in his newest whitepaper, Navigating the Analytical Complexity of Oligonucleotide Therapeutics ➡️https://hubs.li/Q02HNR9q0 #labservices #askalcami #alcami #oligonucleotide #analytical #CDMO